Soil remediation technology has changed significantly over the past two decades, shifting from predominantly physical removal methods toward more targeted, biology-driven approaches that treat contamination in place. The most important driver of this shift is cost: excavating and disposing of contaminated soil is increasingly expensive, disruptive, and in many cases technically impossible beneath existing structures or in areas with high groundwater. The sections below walk through the key questions that project managers and environmental coordinators typically face when dealing with a contaminated site.
What are the main types of soil remediation used today?
The main types of soil remediation used today are excavation and off-site disposal, pump-and-treat systems for groundwater, physical or chemical in-situ treatment, and biological remediation. Each approach targets different contaminant types and site conditions. The choice depends on the nature of the contamination, the depth and extent of the plume, and whether the site is accessible for heavy machinery.
Excavation remains the most familiar method for many project owners. It is direct and produces a measurable result quickly, but it is expensive, generates large volumes of contaminated waste, and becomes impractical when buildings, infrastructure, or high groundwater tables are in the way. Pump-and-treat systems extract contaminated groundwater, treat it above ground, and reinject or discharge the cleaned water, but they can run for decades without fully resolving the source zone.
Chemical in-situ treatment, such as injecting oxidants or reductants into the subsurface, can break down certain contaminants rapidly but requires precise delivery and can alter soil chemistry in ways that complicate long-term monitoring. Biological remediation, which harnesses the metabolic activity of microorganisms already present in the soil or introduced specifically for the purpose, has gained substantial ground as a cost-effective and less invasive alternative, particularly for persistent organic contaminants like chlorinated solvents.
Get in Touch
Let’s Talk Microbial Solutions
Book a conversation with Stijn, our CEO, or send us your request.
| Book an Appointment | Request Information |
How has in-situ bioremediation advanced in recent years?
In-situ bioremediation has advanced through a better understanding of the microbial communities responsible for degradation, more precise delivery systems for nutrients and specialist organisms, and molecular tools that allow practitioners to verify biological activity in real time. The result is a more reliable and measurable process than was possible even ten years ago.
One of the most significant developments is bioaugmentation: the deliberate introduction of microbial consortia that carry specific degradation pathways into a contaminated zone. This is particularly relevant for volatile chlorinated compounds (VOCl), such as perchloroethylene (PCE) and trichloroethylene (TCE), which persist in the subsurface because most naturally occurring soil microbiomes lack the organisms needed for complete reductive dechlorination. Introducing a well-characterized consortium of dechlorinating bacteria, combined with an electron donor to sustain anaerobic conditions, can drive degradation to harmless end products like ethene.
Delivery technology has also improved. Injection networks can now be designed to match the heterogeneity of a specific geological profile, ensuring that treatment reaches low-permeability zones that were previously bypassed. Coupled with better site characterization methods, this means fewer failed treatments and more predictable timelines. Avecom’s biological soil remediation work reflects this progression, applying in-situ bioaugmentation with specialized microbial consortia tailored to the specific contaminant profile and soil matrix of each site.
What is a microcosm test and why is it used before remediation?
A microcosm test is a small-scale laboratory experiment that recreates the conditions of a specific contaminated site using actual soil and groundwater samples from that location. It is used before full-scale remediation to determine whether biological degradation of the target contaminant is feasible under those particular conditions, and at what rate. This avoids committing to a costly field intervention before knowing whether the biology will work.
In practice, a microcosm test involves placing site material in sealed vessels, introducing the relevant microorganisms or electron donors, and monitoring the degradation of the contaminant over several weeks. The results show whether the soil matrix supports the required microbial activity, whether competing processes interfere, and what amendments are needed to optimize performance.
For project managers facing regulatory deadlines or budget constraints, the microcosm test is a low-cost decision tool. A negative result rules out a biological approach early, saving the cost of a failed field trial. A positive result provides the evidence base needed to justify a biological remediation plan to regulators and stakeholders. It also generates the data needed to design the full-scale intervention with realistic parameters rather than generic assumptions.
How do molecular monitoring tools improve soil remediation projects?
Molecular monitoring tools improve soil remediation projects by providing direct, quantitative evidence of microbial activity in the subsurface, rather than relying solely on contaminant concentration measurements that lag behind what is actually happening biologically. Techniques like quantitative PCR (qPCR) and amplicon sequencing allow practitioners to track whether the right organisms are present, active, and increasing in abundance over time.
Traditional monitoring relies on chemical analysis: groundwater samples are taken periodically and sent to a laboratory to measure contaminant concentrations. This approach has a fundamental delay built in, and a temporary plateau in contaminant levels does not tell you whether degradation has stalled or is simply proceeding through an intermediate phase. Molecular tools add a biological layer to that picture.
For a contaminated site undergoing reductive dechlorination, for example, qPCR can quantify the abundance of the specific bacterial groups responsible for each step in the degradation chain. If the organisms are present and growing, the process is working even if contaminant concentrations have not yet dropped to target levels. This kind of data is directly useful for OVAM reporting and for demonstrating to regulators that the remediation is on track. It also allows early detection of problems, such as a shift in redox conditions that inhibits the target organisms, before those problems become costly setbacks.
The environmental biotechnology expertise at Avecom includes molecular soil analysis using both qPCR and amplicon sequencing, integrated into remediation monitoring programs to give site owners continuous, data-driven insight into progress.
When is biological soil remediation a better choice than excavation?
Biological soil remediation is a better choice than excavation when the contamination is deep, widespread, or located beneath existing structures where physical removal is not feasible. It is also preferable when the contaminant type is well-suited to biological degradation, when the project timeline allows for a gradual process, and when minimizing surface disruption is a priority.
The most common scenario where excavation fails as a practical option is chlorinated solvent contamination in dense non-aqueous phase liquid (DNAPL) form. These compounds sink below the water table, spread laterally along geological layers, and create persistent source zones that continue to leach into groundwater for decades. Excavating to the depth and extent required to remove the source is often technically impossible or prohibitively expensive. Biological treatment, delivered in-situ, can address the contamination where it sits.
Biological approaches are also appropriate when a site has already undergone partial excavation but residual contamination remains in areas that cannot be accessed. In these cases, a combined strategy, removing what can be physically excavated and treating the remainder biologically, is often the most pragmatic path. The key question in any such decision is whether the biology will actually work for the specific contaminant and soil conditions at that site, which is exactly what a microcosm feasibility test is designed to answer.
For sites where classical techniques have already been tried without achieving cleanup targets, the biological decontamination approach offers a scientifically grounded alternative rather than simply repeating an approach that has not worked.
What does the future of soil remediation technology look like?
The future of soil remediation technology points toward greater integration of biological methods with digital monitoring, more precise site characterization, and risk-based approaches that prioritize protecting human health and groundwater over achieving arbitrary concentration targets. Biological remediation is expected to become the default approach for many persistent organic contaminants as the evidence base and toolset continue to mature.
Several trends are shaping the direction of the field. Advances in environmental genomics are making it possible to characterize the full microbial community of a contaminated site quickly and affordably, providing a much richer picture of what degradation potential already exists before any intervention is designed. This reduces reliance on generic treatment protocols and supports more site-specific, efficient remediation design.
Risk-based land management frameworks are also gaining traction in regulatory contexts. Rather than requiring all contaminated sites to meet a single cleanup standard regardless of land use, these frameworks allow remediation targets to be calibrated to the actual exposure pathways and intended use of the site. This makes biological approaches, which may achieve stable risk reduction without complete contaminant elimination, more viable within regulatory frameworks.
The role of specialist firms with deep expertise in microbial ecology and process engineering will become more important as projects grow in complexity. Avecom, operating from its roots as a Ghent University spin-out with over 30 years in microbial process management, represents the kind of science-driven capability that increasingly complex contaminated site challenges will require. The combination of laboratory feasibility testing, tailored bioaugmentation, and molecular monitoring provides a complete technical framework for projects where standard approaches have reached their limits.